A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) | MicrobiomeTrials
A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-01-31Est. Completion: 2029-11-13
Enrollment target: 3 participants
Locations
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Other microbiome trials you might be interested in